Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Entheon Biomedical ( (TSE:ENBI) ) is now available.
Entheon Biomedical Corp. has announced the issuance of incentive stock options to certain directors, allowing them to purchase up to 40,000 common shares at $0.145 per share over the next two years. This move is part of the company’s broader incentive stock option plan, aimed at aligning the interests of its directors with the company’s strategic goals, potentially impacting its operational dynamics and market positioning.
More about Entheon Biomedical
Entheon Biomedical Corp. is a biotechnology research and development company focused on treating addiction and substance use disorders.
YTD Price Performance: -37.96%
Average Trading Volume: 2,464
Technical Sentiment Signal: Buy
Current Market Cap: $1.4M
Find detailed analytics on ENBI stock on TipRanks’ Stock Analysis page.